Note: Ingredients listed on restricted chemical lists
EC/CAS
1310-73-2
Name of the chemical
sodium hydroxide
Concentration
>=1-<5
General Information
Version
3.0
Revision date
2024-06-17
Product name
Micardis tablets
Product Synonyms
Micardis® Tablets 20mg, Micardis® Tablets 40mg, Micardis® Tablets 80mg with active ingredient: Telmisartan
1.2.1 Relevant identified uses
Pharmaceutical
1.2.2. Uses advised against
Safety Data Sheet only for the professional user
supplier name
Boehringer Ingelheim Pharmaceuticals Inc
Emergency telephone
+1 703-527-3887, +1 703-741-5970
Icons in SDS
Company Information
company name
Boehringer Ingelheim Pharmaceuticals Inc
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319, H361, H373
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Signal word
Warning
Hazard statements
H315 Causes skin irritation. H319 Causes serious eye irritation. H361 Suspected of damaging fertility or the unborn child. H373 May cause damage to organs (Stomach, Kidney) through prolonged or repeated exposure.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P332 + P313 If skin irritation occurs: Get medical advice/ atten- tion. P337 + P313 If eye irritation persists: Get medical advice/ atten- P362 Take off contaminated clothing and wash before reuse.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste dis- posal plant.
2.3 Other hazards
This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS) The pharmacological effect of the medicament has to be considered (see package leaflet).
2.1 Classification of the substance or mixture
1910.1200) Skin irritation : Category 2 Eye irritation : Category 2A Reproductive toxicity : Category 2 Specific target organ toxicity : Category 2 (Stomach, Kidney) - repeated exposure
